LIANHUA CHEMICAL TECHNOLOGY CO., LTD. ANNOUNCEMENT ON PROGRESS REGARDING JOINT INVESTMENT WITH RELATED PARTIES AND RELATED PARTY TRANSACTIONS

robot
Abstract generation in progress

Log in to Sina Finance App and search for [Information Disclosure] to see more evaluation levels.

The company and all members of the board of directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or major omissions.

  1. Overview of External Investment and Related Transactions

Lianhua Technology Co., Ltd. (hereinafter referred to as “the Company”) held the fifth meeting of the ninth board of directors on March 11, 2026, to review and approve the proposal on joint investment and related transactions with related parties. Director Mr. Fan Xiaobin recused himself from voting. The company agreed that its wholly owned subsidiary, Taizhou Lianhua Equity Investment Co., Ltd. (hereinafter referred to as “Lianhua Investment”), would jointly invest with the company’s director and senior vice president, Mr. Fan Xiaobin, to establish Lianhua Ruituo (Shanghai) Biotechnology Co., Ltd. (hereinafter referred to as “Lianhua Ruituo”). The registered capital is RMB 15 million, with Lianhua Investment contributing RMB 12 million (80%) in cash, and Mr. Fan Xiaobin contributing RMB 3 million (20%) in cash.

For details, see the company’s announcement titled “Announcement on Joint Investment and Related Transactions with Related Parties” published on March 12, 2026, in Securities Times, Shanghai Securities News, and Cninfo (www.cninfo.com.cn) (Announcement No.: 2026-006).

  1. Progress

Recently, the company’s wholly owned subsidiary, Lianhua Investment, and Mr. Fan Xiaobin, the company’s director and senior vice president, officially signed the “Investment Cooperation Agreement.” Lianhua Ruituo has completed registration procedures and obtained the Business License issued by the Shanghai Market Supervision Administration. The specific information is as follows:

  1. Name: Lianhua Ruituo (Shanghai) Biotechnology Co., Ltd.

  2. Unified Social Credit Code: 91310000MAK8Q9429Q

  3. Type: Other joint-stock limited company (non-listed)

  4. Legal representative: Fan Xiaobin

  5. Registered capital: RMB 15,000,000

  6. Date of establishment: March 13, 2026

  7. Address: Building 4, No. 5475 Wenchuan Road, Baoshan District, Shanghai

  8. Business scope: General projects: cell technology research and development and application; technical services, development, consulting, communication, transfer, and promotion; bio-pesticide technology R&D; bio-organic fertilizer R&D; bio-based material polymer technology R&D; biochemical product technology R&D; fermentation process optimization technology R&D; chemical product manufacturing (excluding licensed chemical products); industrial enzyme preparations R&D; manufacturing of special chemical products (excluding hazardous chemicals); manufacturing of basic chemical raw materials (excluding hazardous chemicals and licensed chemicals); chemical product sales (excluding licensed chemical products). (Except for projects that require approval by law, the company conducts business activities independently with its business license.) Licensed projects: fertilizer production; new chemical substance production; pesticide production; bio-pesticide production. (Projects requiring approval by law can only be carried out after approval by relevant departments, with specific business items subject to approval documents or permits.)

  9. Documents for record

  10. Lianhua Ruituo Business License.

This announcement is hereby made.

Lianhua Technology Co., Ltd.

Board of Directors

March 20, 2026

Stock Code: 002250 Stock Abbreviation: Lianhua Technology Announcement No.: 2026-007

Lianhua Technology Co., Ltd. Progress Announcement on Joint Investment and Related Transactions with Related Parties

Massive information, precise interpretation, all on Sina Finance App

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin